Advantages Low entry pricing: The $180 month one cost makes tirzepatide accessible to people who might not otherwise afford to try it Transparent pricing: No hidden fees, no mandatory memberships, no bundled services inflating the cost Quality formulation: The tirzepatide-glycine-B12 combination follows current best practices for compounded GLP-1 medications Flexible purchasing: Autoship and one-time purchase options accommodate different preferences Cold-chain shipping: Proper cold packs and expedited delivery options protect medication stability Physician oversight: Licensed physician review through Blue Drop Health PLLC for every order Additional products: Longevity options including NAD+, L-Carnitine, and glutathione for patients interested in broader health optimization Disadvantages Rising costs: The price jump from $180 to $545 across six months may surprise patients who focused on the entry price No refunds after approval: Once the physician writes your prescription, your payment is final Limited support: No nutrition coaching, no regular check-ins, no progress tracking tools included Unknown pharmacy partners: Citizen Meds does not publicly identify which compounding pharmacies prepare their medications State coverage unclear: No published list of which states they serve Weekend support limited: Phone support goes to voicemail on weekends 48-hour claim window: Shipping issues must be reported within 48 hours of delivery Regulatory uncertainty: Compounded tirzepatide faces an evolving regulatory landscape that could affect availability Who Citizen Meds is best for Citizen Meds works best for self-directed patients who want affordable access to compounded tirzepatide without paying for coaching, counseling, or other bundled services they do not need
This finding accounted for 67% of the observed heterogeneity
Abdelaziz TS, Ali AY, Fatthy M
#46 of 1,452 supplements looked up here in the last 7 days #5 of 2,830 medications looked up here in the last 7 days Position among everything looked up on this site, not a measure of how commonly either one is used or how important it is
Peptide influencers have gone through the back door with this
Back Marks, V (30 June 2006) 'Ellis Samols', The Lancet , 368, 360
